Cargando…

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer

CD133 has been implicated as a cancer stem cell (CSC) surface marker in several malignancies including pancreatic cancer. However, the functional role of this surface glycoprotein in the cancer stem cell remains elusive. In this study, we determined that CD133 overexpression induced “stemness” prope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Alice, Banerjee, Sulagna, Chugh, Rohit, Dudeja, Vikas, Yamamoto, Masato, Vickers, Selwyn M., Saluja, Ashok K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480754/ https://www.ncbi.nlm.nih.gov/pubmed/25829252

Ejemplares similares

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2016)

Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133(+) tumor initiating cells
por: Nomura, Alice, et al.
Publicado: (2016)

MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
por: Banerjee, Sulagna, et al.
Publicado: (2012)

miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
por: Chen, Zhiyu, et al.
Publicado: (2013)

Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence
por: Sharma, Nikita S., et al.
Publicado: (2019)

GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
por: Dauer, Patricia, et al.
Publicado: (2018)

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
por: Sharma, Nikita S, et al.
Publicado: (2019)

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019)

Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019)

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer
por: McGinn, Olivia, et al.
Publicado: (2017)

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer
por: Dauer, Patricia, et al.
Publicado: (2017)

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
por: Dauer, Patricia, et al.
Publicado: (2019)

CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
por: Ding, Qiang, et al.
Publicado: (2014)

Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
por: Rousalova, Ilona, et al.
Publicado: (2013)

Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer
por: Arora, Nivedita, et al.
Publicado: (2017)

New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
por: Jain, Tejeshwar, et al.
Publicado: (2021)

A Theranostic Approach to Target Gastrin in Pancreatic Cancer
por: Banerjee, Sulagna, et al.
Publicado: (2018)

Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells
por: Chen, Linjie, et al.
Publicado: (2018)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer
por: Chen, Yu-Syuan, et al.
Publicado: (2011)

TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
por: Papageorgis, Panagiotis
Publicado: (2015)

Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a
por: Suresh Babu, Vishnu, et al.
Publicado: (2022)

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
por: Gupta, Vineet K., et al.
Publicado: (2020)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
por: Goulioumis, Anastasios, et al.
Publicado: (2022)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Epithelial-mesenchymal transition and metastatic ability of CD133(+) colorectal cancer stem-like cells under hypoxia
por: Okada, Masamichi, et al.
Publicado: (2021)

CD133(+) ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
por: Long, Haixia, et al.
Publicado: (2015)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

Epithelial–mesenchymal transition and its transcription factors
por: Debnath, Pallabi, et al.
Publicado: (2021)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Epithelial‐mesenchymal transition in cancer metastasis through the lymphatic system
por: Karlsson, Mikael C., et al.
Publicado: (2017)

Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
por: Pearson, Gray W.
Publicado: (2019)

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition
por: Behzatoglu, Kemal
Publicado: (2021)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
por: Amin, Amr, et al.
Publicado: (2022)

IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer
por: Lee, Soo Ok, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bo4hri3940ttjdbu116p74nq07